Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Receivables - Net (2017 - 2025)

Historic Receivables - Net for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to $912000.0.

  • Assembly Biosciences' Receivables - Net changed N/A to $912000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $912000.0, marking a year-over-year change of. This contributed to the annual value of $43000.0 for FY2023, which is 9544.49% down from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Receivables - Net is $912000.0.
  • Assembly Biosciences' Receivables - Net's 5-year high stood at $1.2 million during Q3 2022, with a 5-year trough of $43000.0 in Q4 2023.
  • For the 5-year period, Assembly Biosciences' Receivables - Net averaged around $530692.3, with its median value being $523000.0 (2022).
  • In the last 5 years, Assembly Biosciences' Receivables - Net surged by 18095.24% in 2022 and then tumbled by 9544.49% in 2023.
  • Over the past 5 years, Assembly Biosciences' Receivables - Net (Quarter) stood at $336000.0 in 2021, then skyrocketed by 180.95% to $944000.0 in 2022, then crashed by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then soared by 2020.93% to $912000.0 in 2025.
  • Its Receivables - Net stands at $912000.0 for Q3 2025, versus $43000.0 for Q1 2024 and $43000.0 for Q4 2023.